Cognitive function in 18-month-old term infants of the DIAMOND study: a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid.

@article{Drover2011CognitiveFI,
  title={Cognitive function in 18-month-old term infants of the DIAMOND study: a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid.},
  author={James R. Drover and Dennis R. Arellano Hoffman and Yolanda S. Casta{\~n}eda and Sarah E. Morale and Sharon Garfield and Dianna Hughbanks Wheaton and Eileen E Birch},
  journal={Early human development},
  year={2011},
  volume={87 3},
  pages={
          223-30
        }
}
BACKGROUND Studies investigating cognitive outcomes following docosahexaenoic acid (DHA) supplementation of infant formula yield conflicting results, perhaps due to inadequate dietary concentrations. AIM To determine the optimal DHA concentration in term formula to support cognitive maturation. DESIGN This was a double-masked, randomized, controlled, prospective trial. A total of 181 infants were enrolled at 1-9 days of age and assigned randomly to receive one of four term infant formulas… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 29 CITATIONS

Omega 3 fatty acids on child growth, visual acuity and neurodevelopment.

VIEW 7 EXCERPTS
CITES RESULTS, BACKGROUND & METHODS
HIGHLY INFLUENCED